Publikationen 2023
Penile fractures: The price of a Merry Christmas.
BJU Int 2023;
Pyrgidis N, Chaloupka M, Yolz Y, Pfitzinger P, Apfelbeck M, Weinhold P, Stief C, Marcon J, Schulz GB
Single-fraction prostate-specific membrane antigen positron emission tomography- and multiparametric magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer local recurrences.
BJU Int 2023; 131(1): 101-108;
Ehret F, Hofmann T, Fürweger C, Kufeld M, Staehler M, Muacevic A, Haidenberger A
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.
BJUI Compass 2023; 4(1): 123-129;
Bravi CA, Heidenreich A, Fossati N, Gandaglia G, Suardi N, Mazzone E, Stabile A, Cucchiara V, Osmonov D, Juenemann KP, Karnes RJ, Kretschmer A, Buchner A, Stief C, Hiester A, Albers P, Devos G, Joniau S, Van Poppel H, Grubmüller B, Shariat S, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A, Pfister D
Absence of detrusor muscle in TUR-BT specimen - can we predict who is at highest risk?
BMC Urol 2023; 23(1)
Volz Y, Trappmann R, Ebner B, Eismann L, Pyrgidis N, Pfitzinger P, Bischoff R, Schlenker B, Stief C, Schulz GB
Adverse Pathology after Radical Prostatectomy of Patients Eligible for Active Surveillance-A Summary 7 Years after Introducing mpMRI-Guided Biopsy in a Real-World Setting.
Bioengineering (Basel) 2023; 10(2)
Ebner B, Apfelbeck M, Pyrgidis N, Nellessen T, Ledderose S, Pfitzinger PL, Volz Y, Berg E, Enzinger B, Rodler S, Atzler M, Ivanova T, Clevert DA, Stief CG, Chaloupka M
Efficacy and Safety of Platelet-Rich Plasma Injections for the Treatment of Female Sexual Dysfunction and Stress Urinary Incontinence: A Systematic Review.
Biomedicines 2023; 11(11)
Dankova I, Pyrgidis N, Tishukov M, Georgiadou E, Nigdelis MP, Solomayer EF, Marcon J, Stief CG, Hatzichristou D
Interstitial Photodynamic Therapy of Glioblastomas: A Long-Term Follow-up Analysis of Survival and Volumetric MRI Data.
Cancers (Basel) 2023; 15(9)
Foglar M, Aumiller M, Bochmann K, Buchner A, El Fahim M, Quach S, Sroka R, Stepp H, Thon N, Forbrig R, Rühm A
Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy.
Cancers (Basel) 2023; 15(12)
Preisser F, Incesu RB, Rajwa P, Chlosta M, Ahmed M, Abreu AL, Cacciamani G, Ribeiro L, Kretschmer A, Westhofen T, Smith JA, Graefen M, Calleris G, Raskin Y, Gontero P, Joniau S, Sanchez-Salas R, Shariat SF, Gill I, Karnes RJ, Cathcart P, Van Der Poel H, Marra G, Tilki D
P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer.
Cancers (Basel) 2023; 15(8)
Ledderose S, Rodler S, Eismann L, Ledderose G, Rudelius M, Junger WG, Ledderose C
Radical Prostatectomy without Prior Biopsy in Patients with High Suspicion of Prostate Cancer Based on Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen Positron Emission Tomography: A Prospective Cohort Study.
Cancers (Basel) 2023; 15(4)
Chaloupka M, Apfelbeck M, Pyrgidis N, Marcon J, Weinhold P, Stief CG
Robot-Assisted Magnetic Resonance Imaging-Targeted versus Systematic Prostate Biopsy; Systematic Review and Meta-Analysis.
Cancers (Basel) 2023; 15(4)
Petov V, Azilgareeva C, Shpikina A, Morozov A, Krupinov G, Kozlov V, Singla N, Gómez Rivas J, Jesús MS, Puliatti S, Checcucci E, Rodler S, Belenchon IR, Kowalewski KF, Veccia A, Mcfarland J, Cacciamani GE, Taratkin M, Enikeev D
Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not Anecdotal.
Clin Genitourin Cancer 2023;
Staehler M, Rodler S, Brinkmann I, Stief CG, Graser A, Götz M, Herlemann A
mpMRI-targeted biopsy of the prostate in men ≥ 75 years. 7-year report from a high-volume referral center.
Clin Hemorheol Microcirc 2023;
Chaloupka M, Pyrgidis N, Ebner B, Pfitzinger P, Volz Y, Berg E, Abrarova B, Atzler M, Ivanova T, Pfitzinger P, Stief CG, Apfelbeck M, Clevert DA
DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score.
Clin Transl Radiat Oncol 2023; 39
Unger K, Hess J, Link V, Buchner A, Eze C, Li M, Stief C, Kirchner T, Klauschen F, Zitzelsberger H, Niyazi M, Ganswindt U, Schmidt-Hegemann N-S, Belka C
Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy.
Clin Transl Radiat Oncol 2023; 39
Li M, Fan Y, Trapp C, Schmidt-Hegemann NS, Ma J, Buchner A, Lu S, Xu B, Stief C, Wang X, Zhou C, Belka C, Rogowski P
Artificial Intelligence in Surgical Training for Kidney Cancer: A Systematic Review of the Literature.
Diagnostics (Basel) 2023; 13(19)
Rodriguez Peñaranda N, Eissa A, Ferretti S, Bianchi G, Di Bari S, Farinha R, Piazza P, Checcucci E, Belenchón IR, Veccia A, Gomez Rivas J, Taratkin M, Kowalewski KF, Rodler S, De Backer P, Cacciamani GE, De Groote R, Gallagher AG, Mottrie A, Micali S, Puliatti S, YAU Uro-Technology Working Group
The Impact of Prostate Volume on the Prostate Imaging and Reporting Data System (PI-RADS) in a Real-World Setting.
Diagnostics (Basel) 2023; 13(16)
Volz Y, Apfelbeck M, Pyrgidis N, Pfitzinger PL, Berg E, Ebner B, Enzinger B, Ivanova T, Atzler M, Kazmierczak PM, Clevert DA, Stief C, Chaloupka M
Digital Urology.
In R. Huss (Ed.), Digital Medicine: Bringing Digital Solutions to Medical Practice (475-491). Jenny Stanford Publishing, New York, 2023
Buchner A
Operating room team strategies to reduce flow disruptions in high-risk task episodes: resilience in robot-assisted surgery.
Ergonomics 2023; 66(8): 1118-1131
Koch A, Schlenker B, Becker A, Weigl M
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.
Eur J Nucl Med Mol Imaging 2023;
Spohn SKB, Schmidt-Hegemann NS, Ruf J, Mix M, Benndorf M, Bamberg F, Makowski MR, Kirste S, Rühle A, Nouvel J, Sprave T, Vogel MME, Galitsnaya P, Gschwend JE, Gratzke C, Stief C, Löck S, Zwanenburg A, Trapp C, Bernhardt D, Nekolla SG, Li M, Belka C, Combs SE, Eiber M, Unterrainer L, Unterrainer M, Bartenstein P, Grosu AL, Zamboglou C, Peeken JC
Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial.
Eur J Nucl Med Mol Imaging 2023;
Holzgreve A, Unterrainer M, Calais J, Adams T, Oprea-Lager DE, Goffin K, Lopci E, Unterrainer LM, Kramer KKM, Schmidt-Hegemann NS, Casuscelli J, Stief CG, Ricke J, Bartenstein P, Kunz WG, Mehrens D
Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients.
Eur Radiol 2023;
Grawe F, Blom F, Winkelmann M, Burgard C, Schmid-Tannwald C, Unterrainer LM, Sheikh GT, Pfitzinger PL, Kazmierczak P, Cyran CC, Ricke J, Stief CG, Bartenstein P, Ruebenthaler J, Fabritius MP, Geyer T
Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology.
Eur Urol 2023;
Eppler M, Ganjavi C, Ramacciotti LS, Piazza P, Rodler S, Checcucci E, Gomez Rivas J, Kowalewski KF, Belenchón IR, Puliatti S, Taratkin M, Veccia A, Baekelandt L, Teoh JY, Somani BK, Wroclawski M, Abreu A, Porpiglia F, Gill IS, Murphy DG, Canes D, Cacciamani GE
Patients' Trust in Artificial Intelligence-based Decision-making for Localized Prostate Cancer: Results from a Prospective Trial.
Eur Urol Focus 2023;
Rodler S, Kopliku R, Ulrich D, Kaltenhauser A, Casuscelli J, Eismann L, Waidelich R, Buchner A, Butz A, Cacciamani GE, Stief CG, Westhofen T
Complications After Radical Cystectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials with a Meta-regression Analysis.
Eur Urol Focus 2023;
Katsimperis S, Tzelves L, Tandogdu Z, Ta A, Geraghty R, Bellos T, Manolitsis I, Pyrgidis N, Schulz GB, Sridhar A, Shaw G, Kelly J, Skolarikos A
Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis.
Eur Urol Focus 2023;
Schallenberg S, Dragomir MP, Anders P, Ebner B, Volz Y, Eismann L, Rodler S, Casuscelli J, Buchner A, Klauschen F, Stief C, Horst D, Schulz GB
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.
Eur Urol Focus 2023;
Zattoni F, Marra G, Martini A, Kasivisvanathan V, Grummet J, Harkin T, Ploussard G, Olivier J, Chiu PK, Valerio M, Marquis A, Gontero P, Guo H, Zhuang J, Frydenberg M, Moon D, Morlacco A, Kretschmer A, Barletta F, Heidegger I, Tilki D, van den Bergh R, Dal Moro F, Briganti A, Montorsi F, Novara G, Gandaglia G, EAU-YAU Prostate Cancer Working Party
Radiomics Signature Using Manual Versus Automated Segmentation for Lymph Node Staging of Bladder Cancer.
Eur Urol Focus 2023; 9(1): 145-153
Gresser E, Woznicki P, Messmer K, Schreier A, Kunz WG, Ingrisch M, Stief C, Ricke J, Nörenberg D, Buchner A, Schulz GB
Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort.
Eur Urol Focus 2023; 9(4): 645-649
Calleris G, Marra G, Benfant N, Rajwa P, Ahmed M, Abreu A, Cacciamani G, Ghoreifi A, Ribeiro L, Westhofen T, Tourinho-Barbosa R, Raskin Y, Veerman H, Albisinni S, Smith JA, Rouprêt M, Oderda M, Massari E, Persad R, Van Der Poel H, Joniau S, Sanchez-Salas R, Kretschmer A, Cathcart P, Gill I, Karnes RJ, Tilki D, Shariat SF, Touijer K, Gontero P
The Long but Necessary Journey Towards Optimization of the Cause-Effect Relationship Between Input and Output for Accountable Use of ChatGPT for Academic Purposes.
Eur Urol Focus 2023;
Piazza P, Checcucci E, Puliatti S, Belenchòn IR, Veccia A, Rivas JG, Taratkin M, Kowalewski KF, Rodler S, Cacciamani GE, Uro-Technology, Social Media Working Group of the Young Academic Urologists Working Party of the European Association of Urology
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.
Eur Urol Oncol 2023;
Rajwa P, Robesti D, Chaloupka M, Zattoni F, Giesen A, Huebner NA, Krzywon A, Miszczyk M, Moll M, Stando R, Cisero E, Semko S, Checcucci E, Devos G, Apfelbeck M, Gatti C, Marra G, van den Bergh RCN, Goldner G, Rasul S, Ceci F, Dal Moro F, Porpiglia F, Gontero P, Bjartell A, Stief C, Heidenreich A, Joniau S, Briganti A, Shariat SF, Gandaglia G, EAU-Young Academic Urologists (YAU) Prostate Cancer Working Party
Digital Therapeutics in Urology: An Innovative Approach to Patient Care and Management.
Eur Urol Open Sci 2023; 55(): 23-27
Rodler S, Kowalewski KF, Scheibert H, Bensel M, Stadelmeier LF, Styn A, Belenchon IR, Taratkin M, Puliatti S, Gomez Rivas J, Veccia A, Piazza P, Checcucci E, Michel MS, Stief CG, Cacciamani G, Young Academic Urologists Urotechnology Group of the European Association of Urology
Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab.
Front Immunol 2023; Aug 9;14:1186388
Lyu C, Stadlbauer B, Wang L, Buchner A, Pohla H
Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
Front Med (Lausanne) 2023; 9
Sauerbruch T, Hennenberg M, Trebicka J, Schierwagen R
Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003.
Front Pharmacol 2023; 14
Liu Y, Wang R, Huang R, Rutz B, Ciotkowska A, Tamalunas A, Hu S, Trieb M, Waidelich R, Strittmatter F, Stief CG, Hennenberg M
Adrenoceptors in the Lower Urinary Tract.
Handb Exp Pharmacol 2023;
Hennenberg M, Michel MC
The Impact on Urology Residents' Learning of Social Media and Web Technologies after the Pandemic: A Step Forward through the Sharing of Knowledge.
Healthcare (Basel) 2023; 11(13)
Rodler S, Bujoreanu CE, Baekelandt L, Volpi G, Puliatti S, Kowalewski KF, Belenchon IR, Taratkin M, Rivas JG, Veccia A, Piazza P, Carrion DM, Cacciamani GE, Esperto F, Checcucci E
Perioperative outcomes of penile prosthesis implantation in Germany: results from the GRAND study.
Int J Impot Res 2023;
Pyrgidis N, Schulz GB, Chaloupka M, Volz Y, Pfitzinger PL, Rodler S, Berg E, Weinhold P, Jokisch F, Stief CG, Becker AJ, Marcon J
Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board.
J Cancer Res Clin Oncol 2023; 149(5): 1905-1915;
Heinrich K, Miller-Phillips L, Ziemann F, Hasselmann K, Rühlmann K, Flach M, Biro D, von Bergwelt-Baildon M, Holch J, Herold T, von Baumgarten L, Greif PA, Jeremias I, Wuerstlein R, Casuscelli J, Spitzweg C, Seidensticker M, Renz B, Corradini S, Baumeister P, Goni E, Tufman A, Jung A, Kumbrink J, Kirchner T, Klauschen F, Metzeler KH, Heinemann V, Westphalen CB
Prospects of Endovenous Laser Ablation (EVLA) Standardization-Mid-Term Results of a Four-Zone Dosimetry Guiding Tool for 1940 nm Laser.
J Clin Med 2023; 12(13): 4313
Setia A, Dikic S, Demhasaj S, Schmitz-Rixen T, Sroka R, Schmedt CG
A Systematic Review of New Imaging Technologies for Robotic Prostatectomy: From Molecular Imaging to Augmented Reality.
J Clin Med 2023; 12(16): 5425
Rodler S, Kidess MA, Westhofen T, Kowalewski KF, Belenchon IR, Taratkin M, Puliatti S, Gómez Rivas J, Veccia A, Piazza P, Checcucci E, Stief CG, Cacciamani GE
The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study.
J Clin Med 2023; 12(21): 6749
Strobach D, Haimerl L, Mannell H, Stief CG, Karl A, Grimm T, Buchner A
Perioperative outcomes of same-session bilateral versus unilateral ureteroscopy for stone removal: Results from the GRAND study.
J Endourol 2023;
Pyrgidis N, Chaloupka M, Ebner B, Stief C, Weinhold P, Marcon J, Schulz GB
Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer.
J Natl Compr Canc Netw 2023; 21(1): 43-50.e2;
Mehrens D, Kramer KKM, Unterrainer LM, Beyer L, Bartenstein P, Froelich MF, Tollens F, Ricke J, Rübenthaler J, Schmidt-Hegemann NS, Herlemann A, Unterrainer M, Kunz WG
Interstitial photodynamic therapy for newly diagnosed glioblastoma.
J Neurooncol 2023; 162(1): 217-223;
Quach S, Schwartz C, Aumiller M, Foglar M, Schmutzer M, Katzendobler S, El Fahim M, Forbrig R, Bochmann K, Egensperger R, Sroka R, Stepp H, Rühm A, Thon N
An analysis of PSMA-PET/CT-positive lymph node distribution and their coverage by different elective nodal radiation volumes in postoperative prostate cancer patients.
J Nucl Med 2023;
Trapp C, Oliinyk D, Rogowski P, Von Bestenbostel R, Ganswindt U, Li M, Eze C, Bartenstein P, Beyer L, Ilhan H, Sheikh G, Unterrainer L, Stief C, Westhofen T, Kunz WG, Unterrainer M, Belka C, Schmidt-Hegemann NS
Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive Nephrectomy.
J Urol 2023;
Reese SW, Khaleel S, Silagy A, Xie A, Eismann L, Vazquez-Rivera K, Oparanozie A, Patil S, Coleman J, Motzer R, Kotecha RR, Russo P, Voss MH, Hakimi AA
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial.
Lancet 2023; 401(10379): 821-832;
Motzer RJ, Russo P, Grünwald V, Tomita Y, Zurawski B, Parikh O, Buti S, Barthélémy P, Goh JC, Ye D, Lingua A, Lattouf JB, Albigès L, George S, Shuch B, Sosman J, Staehler M, Vázquez Estévez S, Simsek B, Spiridigliozzi J, Chudnovsky A, Bex A
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Lancet Oncol 2023; 24(3): 228-238;
Choueiri TK, Eto M, Motzer R, De Giorgi U, Buchler T, Basappa NS, Méndez-Vidal MJ, Tjulandin S, Hoon Park S, Melichar B, Hutson T, Alemany C, McGregor B, Powles T, Grünwald V, Alekseev B, Rha SY, Kopyltsov E, Kapoor A, Alonso Gordoa T, Goh JC, Staehler M, Merchan JR, Xie R, Perini RF, Mody K, McKenzie J, Porta CG
Silencing of CDC42 inhibits contraction and growth-related functions in prostate stromal cells, which is mimicked by ML141.
Life Sci 2023;
Wang R, Huang R, Liu Y, Tamalunas A, Stief CG, Hennenberg M
[Early detection of prostate cancer].
MMW Fortschr Med 2023; 165(8): 50-52;
Rodler S, Stief CG
[Etiology, diagnostic pathway and treatment of urethral strictures in men].
MMW Fortschr Med 2023; 165(18): 66-69;
Berg EK, Chaloupka M, Götz M, Hoffmann M, Askari-Motlagh D, Stief CG, Bischoff R
[Localized therapy of renal cell carcinoma].
MMW Fortschr Med 2023; 165(13): 34-38;
Brinkmann I, Stief CG, Marcon J
[Editorial].
MMW Fortschr Med 2023; 165(13):
Stief CG
[Systemic treatment of renal cancer and management of immunotherapy related toxicity].
MMW Fortschr Med 2023; 165(13): 39-41;
Berg EK, Aydogdu C, Götz M, Rodler S, Tamalunas A, Stief CG, Casuscelli J
[Urinary tract infections in children].
MMW Fortschr Med 2023; 165(7): 58-59;
Stredele R, Atzler M, Becker KM, Zeller C, Lisec K, Kammer B, Stief CG, Heinrich MB
Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscle.
Naunyn Schmiedebergs Arch Pharmacol 2023;
Hu S, Trieb M, Huang R, Tamalunas A, Keller P, Götz M, Waidelich R, Stief CG, Hennenberg M
Selective inhibition of neurogenic, but not agonist-induced contractions by phospholipase A2 inhibitors points to presynaptic phospholipase A2 functions in contractile neurotransmission to human prostate smooth muscle.
Neurourol Urodyn 2023; 42(7): 1522-1531
Hu S, Huang R, Keller P, Götz M, Tamalunas A, Weinhold P, Waidelich R, Stief CG, Hennenberg M
Quantitative differentiation of minimal-fat angiomyolipomas from renal cell carcinomas using grating-based x-ray phase-contrast computed tomography: An ex vivo study.
PLoS ONE 2023; 18(4)
Birnbacher L, Braunagel M, Willner M, Marschner M, De Marco F, Viermetz M, Auweter S, Notohamiprodjo S, Hellbach K, Notohamiprodjo M, Staehler M, Pfeiffer D, Reiser MF, Pfeiffer F, Herzen J
Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer.
Prostate 2023;
Wang L, Lyu C, Stadlbauer B, Buchner A, Nößner E, Pohla H
The impact of previous inguinal mesh hernioplasty on oncological and patient-reported outcomes following radical prostatectomy.
Prostate 2023; 83(14):1313-1322
Westhofen T, Bensel M, Schlenker B, Becker A, Stief CG, Kretschmer A, Buchner A
A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading.
Prostate Cancer Prostatic Dis 2023;
Morozov A, Taratkin M, Bazarkin A, Rivas JG, Puliatti S, Checcucci E, Belenchon IR, Kowalewski KF, Shpikina A, Singla N, Teoh JYC, Kozlov V, Rodler S, Piazza P, Fajkovic H, Yakimov M, Abreu AL, Cacciamani GE, Enikeev D, Young Academic Urologists (YAU) Working Group in Uro-technology of the European Association of Urology
Enucleation of the prostate as retreatment for recurrent or residual benign prostatic obstruction: a systematic review and a meta-analysis.
Prostate Cancer Prostatic Dis 2023;
Pyrgidis N, Mykoniatis I, Lusuardi L, Schulz GB, Sokolakis I, Stief C, Sountoulides P
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study.
Radiother Oncol 2023;
Scharl S, Zamboglou C, Strouthos I, Farolfi A, Serani F, Lanzafame H, Giuseppe Morganti A, Trapp C, Koerber SA, Debus J, Peeken JC, Vogel MME, Vrachimis A, K B Spohn S, Ruf J, Grosu AL, Ceci F, Fendler WP, Bartenstein P, Kroeze SGC, Guckenberger M, Krafcsik M, Klopscheck C, Fanti S, Hruby G, Emmett L, Belka C, Stief C, Schmidt-Hegemann NS, Henkenberens C, Mayer B, Miksch J, Shelan M, Aebersold DM, Thamm R, Wiegel T
Standard operating procedure to reveal prostate cancer specific volatile organic molecules by infrared spectroscopy.
Spectrochim Acta A Mol Biomol Spectrosc 2023; 304()
Maiti KS, Fill E, Strittmatter F, Volz Y, Sroka R, Apolonski A
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial.
Strahlenther Onkol 2023;
Krug D, Imhoff D, Haidenberger A, Heßler N, Schäfer J, Huttenlocher S, Chatzikonstantinou G, Fürweger C, Ramm U, König IR, Chun F, Staehler M, Rödel C, Muacevic A, Vonthein R, Dunst J, Blanck O
Associations of flow disruptions with patient, staff, and process outcomes: a prospective observational study of robotic-assisted radical prostatectomies.
Surg Endosc 2023; 37(9): 6964-6974
Koch A, Quartucci C, Buchner A, Schlenker B, Becker A, Catchpole K, Weigl M
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial.
Target Oncol 2023;
Motzer RJ, Russo P, Grünwald V, Tomita Y, Zurawski B, Parikh O, Buti S, Barthélémy P, Goh JC, Ye D, Lingua A, Lattouf JB, Albigès L, George S, Shuch B, Sosman J, Staehler M, Vázquez Estévez S, Simsek B, Spiridigliozzi J, Chudnovsky A, Bex A
[Benign Prostate Hyperplasia - Current Medical Therapy, New Developments, and Side Effects].
Ther Umsch 2023; 80(3): 113-122;
Tamalunas A, Keller P, Schott M, Atzler M, Ebner B, Hennenberg M, Stief CG, Magistro G
[Laser Techniques in the Treatment of Benign Prostatic Syndrome].
Ther Umsch 2023; 80(3): 141-146;
Brinkmann I, Schott M, Keller P, Tamalunas A, Atzler M, Ebner B, Stief CG, Magistro G
Non-Invasive Zinc Protoporphyrin Screening Offers Opportunities for Secondary Prevention of Iron Deficiency in Blood Donors.
Transfus Med Hemother 2023; 50(4): 303-312;
Schliemann A, Homann C, Hennig G, Lang A, Holdt LM, Vogeser M, Sroka R, Stepp H, Weinauer F, Quenzel EM
Age and ECOG Performance Status as Predictors of Survival of Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
Urol Int 2023; 107(1): 72-79;
Eismann L, Bohn L, Buchner A, Casuscelli J, Volz Y, Weinhold P, Wülfing C, Waidelich R, Stief CG, Schlenker B, Rodler S
Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma.
Urol Int 2023; (): 1-10;
Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Duensing S, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos F, Walter B, Otto W, Burger M, Erlmeier M, Schrader AJ, Hartmann A, Erlmeier F, Steffens S, German Network Of Kidney Cancer
Methylation status of various gene loci in localized prostate cancer: Novel biomarkers for diagnostics and biochemical recurrence.
Urol Oncol 2023;
Eismann L, von Walter P, Jung A, Chaloupka M, Rodler S, Westhofen T, Buchner A, Stief CG, Stadler T, Schlenker B
[Common errors, pitfalls, and management of complications of prostate biopsy : The most common diagnostic and procedural challenges of transrectal fusion prostate biopsy in the initial diagnosis of clinically significant prostate cancer].
Urologie 2023;
Enzinger B, Pfitzinger PL, Ebner B, Ivanova T, Volz Y, Apfelbeck M, Kazmierczak P, Stief C, Chaloupka M
[Current state of prostate biopsy].
Urologie 2023; 62(5): 447-448;
Stief CG
[Digitalization in urology-challenge and opportunity].
Urologie 2023; 62(9): 913-928;
AK Informationstechnologie und Dokumentation (IT@DOC) (DGU), AK Versorgungsforschung, Qualität und Ökonomie (DGU) , AK Informationstechnologie und Dokumentation (IT@DOC) (DGU) , AK Versorgungsforschung, Qualität und Ökonomie (DGU) , AK Bildgebende Systeme (DGU), Sektion Urologie (DEGUM) , Witzsch UKF, Borkowetz A, Enzmann T, Rodler S, Leyh-Bannurah SR, Loch T, Borgmann H, Steidle O
[Transrectal vs. transperineal fusion biopsy of the prostate : Time to switch to the perineal technique-comparison of methods and description of the transperineal procedure under local anesthesia].
Urologie 2023;
Pfitzinger PL, Enzinger B, Ebner B, Ivanova T, Volz Y, Chaloupka M, Apfelbeck M, Stief C
Efficacy, Efficiency, and Safety of En-bloc vs. Three-lobe Enucleation of the Prostate: A Propensity Score-Matched Analysis.
Urology 2023;
Tamalunas A, Schott M, Keller P, Atzler M, Ebner B, Hennenberg M, Stief CG, Magistro G
The impact of laser energy on functional outcome following Holmium Laser Enucleation of the prostate.
Urology 2023;
Westhofen T, Buchner A, Eismann L, Rodler S, Keller P, Atzler M, Jokisch F, Waidelich R, Stief ABCG, Weinhold P
Characterization of Human Papilloma Virus in Prostate Cancer Patients Undergoing Radical Prostatectomy-A Prospective Study of 140 Patients.
Viruses 2023; 15(6)
Nellessen T, Ebner B, Pyrgidis N, Ledderose S, Kretschmer A, Marcon J, Teupser D, Mayr D, Faihs V, Stief CG, French LE, Herlemann A, Reinholz M
Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States.
World J Mens Health 2023;
Han JH, Herlemann A, Washington SL, Lonergan PE, Carroll PR, Cooperberg MR, Jeong CW
Assessment of single-probe dual-energy lithotripters in percutaneous nephrolithotomy: a systematic review and meta-analysis of preclinical and clinical studies.
World J Urol 2023;
Mykoniatis I, Pyrgidis N, Tzelves L, Pietropaolo A, Juliebø-Jones P, De Coninck V, Hameed BMZ, Chaloupka M, Schulz GB, Stief C, Kallidonis P, Somani BK, Skolarikos A